IL-2-5344 has also shown efficacy in suppressing experimental food allergy in mice [130], and IL-2-5111.2 favored the expansion of Tregs in humanized mice and halted progression of T1D, EAE, and GvHD [131]. This evidence concerns the gene IL2 and graft versus host disease.